Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 213 Pages
From
Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H1 2018 - Product Thumbnail Image

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H1 2018

  • Report
  • 68 Pages
From
Lysosomal Storage Disorder Therapeutics Pipeline Analysis 2017 - Product Thumbnail Image

Lysosomal Storage Disorder Therapeutics Pipeline Analysis 2017

  • Report
  • 222 Pages
From
Metabolic Disorders Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023 - Product Thumbnail Image

Metabolic Disorders Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023

  • Report
  • 100 Pages
From
Global Lysosomal Storage Diseases Market 2017-2021 - Product Thumbnail Image

Global Lysosomal Storage Diseases Market 2017-2021

  • Report
  • 104 Pages
From
Global Pompe Disease Treatment Market 2016-2020 - Product Thumbnail Image

Global Pompe Disease Treatment Market 2016-2020

  • Report
  • 65 Pages
From
Global Diabetic Therapeutic Market 2017-2021 - Product Thumbnail Image

Global Diabetic Therapeutic Market 2017-2021

  • Report
  • 167 Pages
From
Global Metabolic Disorders Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Metabolic Disorders Therapeutics Market 2016-2020

  • Report
  • 163 Pages
From
Global Metabolic Disorders Therapeutics Market: Trend Analysis and Forecast to 2022 - Product Thumbnail Image

Global Metabolic Disorders Therapeutics Market: Trend Analysis and Forecast to 2022

  • Report
  • 100 Pages
From
Fabry Disease - Market Insights, Epidemiology and Market Forecast - 2025 - Product Thumbnail Image

Fabry Disease - Market Insights, Epidemiology and Market Forecast - 2025

  • Drug Pipelines
  • 70 Pages
From
Pompe Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Pompe Disease - Pipeline Review, H1 2018

  • Report
  • 69 Pages
From
Fabry Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Fabry Disease - Pipeline Review, H1 2018

  • Report
  • 84 Pages
From
Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 - Product Thumbnail Image

Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018

  • Drug Pipelines
  • 59 Pages
From
Pompe Disease - Pipeline Review, H2 2017 - Product Thumbnail Image

Pompe Disease - Pipeline Review, H2 2017

  • Report
  • 64 Pages
From
Pompe Disease - Pipeline Insight, 2018 - Product Thumbnail Image

Pompe Disease - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
BioMarin's BMN-701 for Pompe Disease - Product Thumbnail Image

BioMarin's BMN-701 for Pompe Disease

  • Report
  • 33 Pages
From
Lysosomal Storage Disorder - Pipeline Review, H2 2015 - Product Thumbnail Image

Lysosomal Storage Disorder - Pipeline Review, H2 2015

  • Report
  • 78 Pages
From
Gaucher's Disease - Pipeline Review, H2 2015 - Product Thumbnail Image

Gaucher's Disease - Pipeline Review, H2 2015

  • Report
  • 86 Pages
From
Lysosomal Storage Disorder - Pipeline Review, H1 2015 - Product Thumbnail Image

Lysosomal Storage Disorder - Pipeline Review, H1 2015

  • Report
  • 105 Pages
From
The 2018-2023 World Outlook for Myelofibrosis (MF) Pharmaceutical Treatments - Product Thumbnail Image

The 2018-2023 World Outlook for Myelofibrosis (MF) Pharmaceutical Treatments

  • Report
  • 306 Pages
Loading Indicator
adroll